Lupus Low Disease Activity State Achievement Is Important for Reducing Adverse Outcomes in Pregnant Patients With Systemic Lupus Erythematosus

Author:

Kim Ji-WonORCID,Jung Ju-YangORCID,Kim Hyoun-AhORCID,Yang Jeong I.,Kwak Dong W.,Suh Chang-HeeORCID

Abstract

ObjectiveThis study aimed to examine the frequency and risk factors of complications during pregnancy in women with systemic lupus erythematosus (SLE).MethodsThe medical records of patients with SLE and age-matched controls at Ajou University Hospital were collected. Clinical features and pregnancy complications in women with SLE were compared to those of the controls. Multivariate logistic regression analysis was performed to determine the predictors of adverse maternal and fetal outcomes.ResultsWe analyzed 163 pregnancies in patients with SLE and 596 pregnancies in the general population; no significant differences regarding demographic characteristics were noted. Patients with SLE experienced a higher rate of stillbirth (OR 13.2), preeclampsia (OR 4.3), preterm delivery (OR 2.8), intrauterine growth retardation (OR 2.5), admission to neonatal intensive care unit (OR 2.2), and emergency cesarean section (OR 1.9) than the control group. Multivariate regression analysis revealed that thrombocytopenia, low complement, high proteinuria, high SLE Disease Activity Index (SLEDAI), low Lupus Low Disease Activity State (LLDAS) achievement rate, and high corticosteroid (CS) dose were associated with adverse pregnancy outcomes. In the receiver-operating characteristic curve analysis, the optimal cutoff value for the cumulative and mean CS doses were 3500 mg and 6 mg, respectively.ConclusionPregnant women with SLE have a higher risk of adverse pregnancy outcomes. Pregnancies are recommended to be delayed until achieving LLDAS and should be closely monitored with the lowest possible dose of CS.

Publisher

The Journal of Rheumatology

Subject

Immunology,Immunology and Allergy,Rheumatology

Reference46 articles.

1. Pregnancy outcomes in systemic lupus erythematosus (SLE) women;Kalok;Horm Mol Biol Clin Investig,2019

2. Petri M , Kallas R. Lupus in pregnancy. Contemp Ob Gyn 2019;64 No 03. [Internet. Accessed January 21, 2021.] Available from: www.contemporaryobgyn.net/pregnancy-and-birth/lupus-pregnancy

3. Ordi-Ros J , Marce CS , Cortes-Hernandez J. Lupus pregnancy: risk factors and management. In: Lionaki S , ed. Lupus – new advances and challenges. [Internet. Accessed February 8, 2021.] Available from: www.intechopen.com/books/lupus-new-advances-and-challenges/lupus-pregnancy-risk-factors-and-management

4. Chakravarty EF , Sammaritano LR. Pregnancy and autoimmune disease, reproductive and hormonal issues. In: Wallace D , Hahn B. Dubois’ lupus erythematosus and related syndromes 9th ed. Elsevier; 2019:499-519.

5. Frequency of lupus flare in pregnancy: the Hopkins Lupus Pregnancy Center experience;Petri;Arthritis Rheum,1991

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3